RMD 投資分析

看多重點:

  • 價值≥4
  • 股利≥2

分析結論

價值面獲得最高評分,股利評分優異,值得長期累積部位。若想獲得較好的進場時機,可參考技術面趨勢與波段評分

RMD 近期報酬表現

3.87%

Resmed inc.

7.48%

同產業平均

-0.88%

S&P500

與 RMD 同產業的標的表現

  • IDXX Idexx laboratories incorporated
    價值 4 分趨勢 2 分波段 2 分籌碼 3 分股利 1 分
    查看更多

RMD 公司資訊

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company's segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

RMD 股價